Gary M Hunninghake

Director, Interstitial Lung Disease Program

Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, US

  • OrcidID


Personal History

Dr Gary Matthew Hunninghake is a Pulmonologist and Genetic Epidemiologist based in Boston, MA.


Academic History

In 1999, Dr Hunninghake received his M.D. from the University of Iowa College of Medicine (now the Roy J. and Lucille A. Carver College of Medicine). He then completed a Residency in Internal Medicine and a Chief Residency (1999 - 2002) at the Medical College of Virginia Hospitals (now the Virginia Commonwealth University Medical Center) followed by a Fellowship in Pulmonary Disease at BWH (2003 - 2007).3

He has a Master’s degree in Public Health (MPH) from the Harvard School of Public Health and is board certified in critical care medicine and pulmonary disease.1, 2


Career Overview

Dr Hunninghake is the Director of the Interstitial Lung Disease Program and an Assistant Professor of Medicine at Brigham and Women's Hospital/Harvard Medical School.1, 2

Dr Hunninghake’s clinical interests include interstitial lung disease, connective tissue disease, pulmonary fibrosis and sarcoidosis. As a member of the BWH Respiratory Genetics Center and the Interstitial Lung Disease (ILD) clinic, his research applied new technologies of genome-wide association, integrative genomics, epigenetics and pharmacogenetics to ILD.1, 2

He has authored over 40 peer-reviewed publications and has received funding from the National Institutes of Health. His NIH funded investigator research is focused on identifying the epidemiologic, genetic and epigenetic factors that will help to diagnose the early stages of idiopathic pulmonary fibrosis (IPF).1, 2


Career Timeline

  • Present: Associate Professor of Medicine (Pulmonary and Critical Care Medicine), Brigham and Women's Hospital, Boston, MA
  • Present: Director, Interstitial Lung Disease Program, Brigham and Women's Hospital


Areas of Speciality

  • Pulmonology





Articles by Gary M Hunninghake, Director, Interstitial Lung Disease Program

Cardiac Sarcoidosis: When and How to Treat Inflammation

Gerard T Giblin, Laura Murphy, Garrick C Stewart, et al


Citation: Cardiac Failure Review 2021;7:e17.